<DOC>
	<DOCNO>NCT02739867</DOCNO>
	<brief_summary>Among patient first episode unprovoked venous thromboembolism ( VTE ) , contemporary one-year risk detect occult cancer approximately 4 % 7 % . Of case , 30 % 60 % miss routine limited screening cancer . RNA profile platelet promise , highly accurate biomarker cancer detection , clinical utility patient unprovoked VTE unknown . The objective present study evaluate diagnostic accuracy platelet RNA profile detect occult cancer patient unprovoked venous thromboembolism . Secondary objective include evaluation biomarkers cancer , prediction bleeding , prediction recurrent VTE .</brief_summary>
	<brief_title>Tumor-educated Platelets Venous Thromboembolism</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<criteria>First episode objectively confirm , symptomatic , unprovoked symptomatic pulmonary embolism and/or distal proximal deep vein thrombosis leg Age 40 year old Written inform consent know malignant disease prior VTE define cancer diagnosis cancer treatment within past 5 year ( note : suspect unconfirmed cancer diagnosis VTE allow ) ; trauma fracture leg , surgical procedure , general anesthesia , immobilization great 3 day within previous 3 month ; previous unprovoked venous thromboembolism ; know hereditary acquire thrombophilia ; current pregnancy puerperium ( 3 month postpartum ) ; current estrogen therapy . Greater 10 day VTE diagnosis ; Inability blood withdrawal baseline ; Inability refusal provide write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>occult cancer</keyword>
	<keyword>venous thromboembolism</keyword>
	<keyword>tumor-educated platelet</keyword>
	<keyword>platelet RNA profiling</keyword>
	<keyword>early diagnosis</keyword>
	<keyword>screen</keyword>
</DOC>